Who We Are
Relay Therapeutics' Approach
Relay Therapeutics was built upon unparalleled insights into protein motion and how this dynamic behavior relates to protein function. These insights are driven by our Dynamo platform, which integrates an array of leading-edge experimental and computational approaches and enables us to effectively drug protein targets that have previously been intractable or inadequately addressed.
Three important forces led to the
founding of Relay Therapeutics:
The genomic revolution has enabled a better understanding of the targets that drive disease, and which patients may benefit from new targeted therapies.
Structural biology techniques emerged that finally allow scientists to visualize protein motion at atomic resolutions.
Computational Power and Speed
Technology improved to the point that molecular dynamics simulations can be run on proteins at biologically relevant timescales useful for drug discovery.
We are advancing a pipeline of promising therapeutic candidates, with an initial focus on precision oncology and genetic disease.